Inmolecule Nanotech S.A. is a biotechnology company specializing in the research, development, and commercialization of plant-derived compounds at the nanoscale. The company’s core innovation lies in its proprietary nano-phytochemistry platform, which enables the creation of active ingredient nanoparticles from botanical sources. These nanomaterials are designed for enhanced safety and efficacy, and are utilized across multiple sectors, including health care, home and personal care, agriculture, aquaculture, and pharmaceuticals. Notable product applications include surface disinfectants and dietary supplements incorporating nano-encapsulated nutrients such as vitamin C and zinc.

By leveraging advances in nanotechnology, Inmolecule Nanotech aims to exploit the unique properties of materials at the 1–100 nanometer scale, resulting in improved bioavailability, reduced toxicity, and minimized side effects in its products. The company operates with a vision to set a global standard in nanobiotechnology, focusing on sustainable solutions that harness the benefits of plant compounds, such as flavonoids and terpenes, while minimizing environmental impact. Headquartered in Madrid and established in 1999, Inmolecule Nanotech plays a pioneering role in integrating advanced nano-scale science into consumer and industrial applications.